We take great responsibility to help improve patients’ lives and see ourselves as a vital link between our customers and their patients – together, we create a safe and innovative healthcare environment of tomorrow. Our state-of-the-art solutions for parenteral drug packaging are supplied to leading pharmaceutical and biotech companies worldwide.
At Datwyler, we are dedicated to meeting customer expectations by guaranteeing the highest level of quality and safety and continuing to make investments aimed at meeting the ever-changing regulatory requirements of the industry. Thanks to our sophisticated product know-how, high-quality manufacturing processes provided on a global scale, and our strong partnerships, we offer best-in-class solutions and enable our customers around the globe to realize their full healthcare potential.
Latest news
Sustainable healthcare solutions for the pharma industry
Datwyler’s award-winning sustainability work is helping the global pharmaceutical market transform into a greener, more environmentally friendly industry.
Datwyler adds steam sterilization option for ready-to-use components for injectable drugs
Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of 2 years after steam sterilization.
Datwyler recognized for Environmental Excellence by Pharmaceutical Technology
The Environmental category highlights companies that are undertaking projects that reduce their impact on the natural environment.
Datwyler to double capacity at its Indian facility
Datwyler is increasing capacity for all three of its production standards in Pune, India. The expansion will nearly double capacity and add 400 jobs.
Datwyler launches 5/8-inch rigid needle shield, infusion discs
New solutions expand the company’s portfolio of elastomer components to meet growing and changing patient needs.
Datwyler Healthcare CEO on acquisition of Yantai Xinhui Packing
China has one of the fastest growing pharmaceutical markets in the world, which means a rising need for high-end packaging components naturally follows. To serve the demand and complete its global footprint, leading parenteral packaging component provider Datwyler recently announced its acquisition of Yantai Xinhui Packing, which includes a state-of-the-art production plant in Yantai, China.
During Challenging Times, The Path to Patient Safety Starts with Datwyler.
At Datwyler, we put care, quality, and drug integrity first. Because we care.
Upcoming events
IMAPAC Vaccines World Summit
PDA Annual Meeting 2023
Booth #209
World Vaccine Congress
22nd China Biological Products Annual Conference (CBioPC)
Booth #C08
Brochures
Datwyler in the media
Datwyler adds steam sterilisation option for ready-to-use components for injectable drugs
Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of two years after steam sterilization.
How smart manufacturing is optimising processes and reducing costs in the pharma supply chain
Tom Lenaerts, Head of Global Process Engineering for Datwyler, speaks about smart manufacturing benefits in the pharma supply chain.
«PERFECTing» the package selection process
Gabrielle Gehron, Scientific Support Manager, Datwyler, explains how one can successfully analyse packaging needs and navigate through the packaging selection process
Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic
As prefilled syringes gain favor with healthcare providers, it’s time to look at how vaccine manufacturers can optimise designs to strengthen their parenteral packaging toolbox.
«Strategically stronger positioned than ever before.»
In an interview with the Swiss online portal moneycab, Datwyler CEO Dirk Lambrecht explains the acquisitions completed in 2022 and how this has increased Datwyler's diversification.
Join us
Visit our Datwyler Healthcare social media channels and join us on our journey.
